Organization · Type 2 NPI
Total Renal Care Inc
End-Stage Renal Disease (ESRD) Treatment Clinic/Center · Lancaster, CA
NPI number
1083898001
Active
Practice location
1759 W Avenue J, Ste 102
Lancaster, CA 93534-2703
Fax (661) 729-3985
Mailing address
5200 Virginia Way, L&c Dept
Brentwood, TN 37027-7569
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| End-Stage Renal Disease (ESRD) Treatment Clinic/Center Primary | 261QE0700X | 930000210 (CA) |
End-Stage Renal Disease (ESRD) Treatment Clinic/Center: Definition to come...
6 other providers at this address
- Bassam A. Hadaya, MDNephrology Physician Lancaster, CA NPI 1801864301
- Bassel Hadaya, MDNephrology Physician Lancaster, CA NPI 1174629950
- Ghassan S. Dahhan, MDNephrology Physician Lancaster, CA NPI 1821066325
- Nanette Chua Fonte, MDNephrology Physician Lancaster, CA NPI 1962732974
- Rendell Esmane Manalo, DONephrology Physician Lancaster, CA NPI 1265610950
- Sung Chul Yang, MDNephrology Physician Lancaster, CA NPI 1871562900
Other end-stage renal disease (esrd) treatment clinic/center providers in Lancaster
- Montress Dialysis LLCEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center Lancaster, CA NPI 1255016747
- Bio-Medical Applications of California, Inc.End-Stage Renal Disease (ESRD) Treatment Clinic/Center Lancaster, CA NPI 1407968209
- Antelope Valley Dialysis Center Medical Group, IncEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center Lancaster, CA NPI 1730285818
- Antelope Valley Kidney Institute, A Professional CorporationEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center Lancaster, CA NPI 1770609711
- Bio-Medical Applications of California, Inc.End-Stage Renal Disease (ESRD) Treatment Clinic/Center Lancaster, CA NPI 1841194107
About NPI 1083898001
Total Renal Care Inc's National Provider Identifier is 1083898001, issued on Dec 27, 2007. The primary taxonomy on file is End-Stage Renal Disease (ESRD) Treatment Clinic/Center (261QE0700X), and the practice location is in Lancaster, CA. The record was last updated on Sep 25, 2025.